Cytotoxicity assessment of ma-huang (Ephedra) under different conditions of preparation

被引:55
作者
Lee, MK
Cheng, BWH
Che, CT
Hsieh, DPH [1 ]
机构
[1] Hong Kong Univ Sci & Technol, Dept Biol, Kowloon, Hong Kong, Peoples R China
[2] Hong Kong Univ Sci & Technol, Dept Chem, Kowloon, Hong Kong, Peoples R China
关键词
cytotoxicity; Ephedra; ephedrine; ephedrine-to-toxins ratio; herb preparations; ma-huang; MTT colorimetry;
D O I
10.1093/toxsci/56.2.424
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Ma-huang is a traditional Chinese medicinal herb derived from Ephedra sinica Stapf and other Ephedra species, used to treat asthma, nose and lung congestion, and fever with anhidrosis. It contains 0.5-2.5% by weight of total alkaloids, of which ephedrine accounts for 30 to 90%. Recently, large amounts of ma-huang were used as a source of ephedrine in many dietary supplements formulated for weight reduction, because ephedrine has been found effective in inducing weight loss in diet-restricted obese patients. However, indiscriminate consumption of ma-huang-containing products has resulted in many cases of poisoning, some of which were fatal. The objective of this study is to investigate the relative toxicity of ma-huang extracted under different conditions. The toxicities of various extracts were assayed using MTT colorimetry on a battery of cell lines, while ephedrine alkaloids were analyzed with HPLC. The results are summarized as follows. (1) The cytotoxicity of all ma-huang extracts could not be totally accounted for by their ephedrine contents, suggesting the presence of other toxins in the extracts. (2) Grinding was a significant condition enhancing the toxicity of the extracts. (3) The relatively high sensitivity of the Neuro-2a cell line to the toxicity of ma-huang extracts suggests that the toxic principles were acting on neuronal cells. (4) One condition to produce a ma-huang extract with high ephedrine-to-toxins ratio would be to boil the whole herb for two h.
引用
收藏
页码:424 / 430
页数:7
相关论文
共 40 条
[1]  
ASTRUP A, 1992, American Journal of Clinical Nutrition, V55, p246S, DOI 10.1093/ajcn/55.1.246s
[2]  
CAPWELL RR, 1995, AM J PSYCHIAT, V152, P647
[3]  
Cetaruk Edward W., 1994, Emergency Medicine Clinics of North America, V12, P483
[4]  
CHEN KK, 1930, EPHEDRINE RELATED SU, P1
[5]  
Cui J.F., 1991, ACTA PHARM SIN, V26, P852
[6]  
De Ferrari GV, 1998, J NEUROSCI RES, V52, P435, DOI 10.1002/(SICI)1097-4547(19980515)52:4<435::AID-JNR7>3.0.CO
[7]  
2-A
[8]  
DOLLERY SC, 1991, THERAPEUTIC DRUGS, pE26
[9]   THE INFLUENCE OF CULTURE-MEDIUM COMPOSITION ON DRUG-METABOLIZING ENZYME-ACTIVITIES OF THE HUMAN-LIVER DERIVED HEP-G2 CELL-LINE [J].
DOOSTDAR, H ;
DUTHIE, SJ ;
BURKE, MD ;
MELVIN, WT ;
GRANT, MH .
FEBS LETTERS, 1988, 241 (1-2) :15-18
[10]  
DULLOO AG, 1993, INT J OBESITY, V17, pS1